Skip to main content
Fig. 4 | Cost Effectiveness and Resource Allocation

Fig. 4

From: Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

Fig. 4

a Tornado diagram for the one-way sensitivity analysis of the cost analysis (healthcare perspective); b Histogram of the lifetime cost difference for the probabilistic sensitivity analysis (healthcare perspective); c Tornado diagram for the one-way sensitivity analysis of the cost analysis (patient perspective); d Histogram of the lifetime cost difference for the probabilistic sensitivity analysis (patient perspective)

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us